SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-051097
Filing Date
2009-08-24
Accepted
2009-08-21 17:53:12
Documents
5
Period of Report
2009-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-23774_18k.htm 8-K 33006
2 EX-1.1 a09-23774_1ex1d1.htm EX-1.1 242883
3 EX-4.1 a09-23774_1ex4d1.htm EX-4.1 121029
4 EX-5.1 a09-23774_1ex5d1.htm EX-5.1 14207
5 EX-99.1 a09-23774_1ex99d1.htm EX-99.1 10159
  Complete submission text file 0001104659-09-051097.txt   422904
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 091029394
SIC: 2834 Pharmaceutical Preparations